A major new insight into how Hepatitis B virus works could pave the way for new drug treatments for the infection, which is the major cause of liver cancer worldwide.
The team at the Universities of York and Leeds identified an “assembly code” in the genetic material of Hepatitis B virus that allows it to create a protective casing in which it can produce new infectious virus particles.
They found that the signal, generated by ribonucleic acid (RNA), helps viral proteins to overcome an ‘engineering problem’, assembling them into in a particular geometric pattern.
Molecular machine
Professor Reidun Twarock, mathematical biologist at the University of York’s Department of Mathematics and Biology, said: “It is a bit like the chain on a bicycle. If we don’t assemble the chain on the sprockets, it becomes tangled and won’t function. Once assembled correctly, it connects the pedals with the wheels allowing the component parts to work together.
“We see the same process happening between the Hepatitis B RNA signals and the viral proteins. The proteins are attracted by these signals, which then promote their assembly into a precise molecular machine that allows the virus to produce a DNA copy of its genetic material and hence become infectious.”
The virus is transmitted through blood and bodily fluids. It is thought that more than two billion people have been infected worldwide, and around 350 million people remain carriers of the infection, which can, over time, result in their deaths.
Potential drug
The virus occurs in Europe but is much more common in parts of Asia, especially China and Africa. There are more than one million infected people in the USA where treatments can include expensive drugs and even liver transplantation.
Professor Peter Stockley, a structural virologist from the University of Leeds Astbury Centre, said: “There is a vaccine for the virus, but once you have the condition there is no treatment, other than drugs that can reduce symptoms but not change the long-term outlook.
“We often compare the disease to HIV due to the way in which the virus is passed from person-to-person, but unlike HIV there are no effective drugs to improve quality of life outcomes. Now that we know how the virus assembles, we can interrupt the interactions with the RNA signals – a bit like when a twig catches the sprocket on a bike, knocking the chain off.”
Learn more: Scientists step closer to drug treatment for Hepatitis B
The Latest on: Hepatitis B
[google_news title=”” keyword=”Hepatitis B” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Immunoassay analyzer extends menu with new hepatitis assayson April 17, 2024 at 4:10 am
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) that it has ...
- Viral hepatitis is a silent killer. It can’t be eliminated if it isn’t trackedon April 17, 2024 at 1:30 am
Before Covid emerged, viral hepatitis killed more people in the United States than all 60 other reportable infectious diseases combined.
- New Hepatitis B Guidelines Address Testing, Treatment Barriers — WHOon April 16, 2024 at 10:11 pm
The World Health Organization (WHO) has announced an update to guidance on the prevention, diagnosis, and treatment of chronic hepatitis B (HBV) infection at the 2024 Asian Pacific Conference for the ...
- VIR-2218 + VIR- 3434 for Chronic Hepatitis B Drug Landscape Report 2024: 7MM Market Size, Forecast, and Emerging Insights 2019-2032on April 16, 2024 at 2:16 am
VIR- 3434 Market Size, Forecast, and Emerging Insight - 2032" report has been added tAndMarkets.com's offering."VIR-2218 + VIR- 3434 Market Size, Forecast, and Emerging Insight - 2032" report provides ...
- Accelerated Hepatitis B Vaccination Appears Safe, Effective in CKDon April 15, 2024 at 5:00 pm
An accelerated hepatitis B vaccination regimen can safely and effectively achieve rapid seroconversion in patients with advanced CKD before they initiate hemodialysis or undergo kidney transplantation ...
- Accelerated Hepatitis B Vaccination Appears Safe, Effective in CKDon April 14, 2024 at 5:00 pm
An accelerated hepatitis B vaccination regimen can safely and effectively achieve rapid seroconversion in patients with advanced CKD before they initiate hemodialysis or undergo kidney ...
- India recorded 3.5 crore hepatitis B and C cases in 2022: WHO reporton April 12, 2024 at 10:30 pm
The WHO's report underscores India's significant struggle with hepatitis B and C, contributing to a global crisis. Urgent actions are needed to combat the rising number of cases and prevent further ...
- Hepatitis on track to overtake TB as world’s biggest infectious killeron April 12, 2024 at 4:00 am
Viral hepatitis is set to become the world’s biggest infectious killer, taking over from tuberculosis (TB) for the first time, new data reveals.
- Hepatitis B, C Rising With India Ranking 2nd in WHO List: Differences Between The Two And Preventive Measureson April 12, 2024 at 2:41 am
Hepatitis B and C are very close to each other in nature Knowing the differences between the two can help you stay safe from Hepatitis ...
- Researchers Decode the Mechanism of Action of Hepatitis B and D Virus Inhibitoron April 11, 2024 at 1:31 am
The molecular mechanisms behind the action of the hepatitis B and D virus inhibitor bulevirtide have been revealed, potentially paving the way to more targeted treatments.
via Google News and Bing News